Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Medtronic
Johnson and Johnson
Dow
Mallinckrodt

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Mepolizumab

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Mepolizumab: Patents, clinical trial progress, indications

Mepolizumab is an investigational drug.

There have been 44 clinical trials for Mepolizumab. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2018.

The most common disease conditions in clinical trials are Asthma, Syndrome, and Hypereosinophilic Syndrome. The leading clinical trial sponsors are GlaxoSmithKline, St. Joseph's Healthcare Hamilton, and National Institute of Allergy and Infectious Diseases (NIAID).

There are twenty-seven US patents protecting this investigational drug and three hundred and eighty international patents.

Recent Clinical Trials for Mepolizumab
TitleSponsorPhase
Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic TrialGlaxoSmithKlinePhase 2/Phase 3
Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic TrialLeicester Clinical Trials UnitPhase 2/Phase 3
Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic TrialUniversity of LeicesterPhase 2/Phase 3

See all Mepolizumab clinical trials

Clinical Trial Summary for Mepolizumab

Top disease conditions for Mepolizumab
Top clinical trial sponsors for Mepolizumab

See all Mepolizumab clinical trials

US Patents for Mepolizumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Mepolizumab   See Pricing Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders Knopp Biosciences LLC (Pittsburgh, PA)   See Pricing
Mepolizumab   See Pricing Compositions comprising oxo-derivatives of fatty acids and methods of making and using same DS BIOPHARMA LIMITED (Dublin, IE)   See Pricing
Mepolizumab   See Pricing Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE)   See Pricing
Mepolizumab   See Pricing Compositions and methods for treating chronic urticaria Knopp Biosciences LLC (Pittsburgh, PA)   See Pricing
Mepolizumab   See Pricing Soft lozenge compositions Patheon Softgels, Inc. (High Point, NC)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Mepolizumab

Drugname Country Document Number Estimated Expiration Related US Patent
Mepolizumab Australia 2014287067 2033-07-12   See Pricing
Mepolizumab Australia 2014306597 2033-07-12   See Pricing
Mepolizumab Australia 2014306683 2033-07-12   See Pricing
Mepolizumab Australia 2017276231 2033-07-12   See Pricing
Mepolizumab Canada 2918035 2033-07-12   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Mallinckrodt
Moodys
Medtronic
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.